High frequency of virus-specific B lymphocytes in germinal centers of simian-human immunodeficiency virus-infected rhesus monkeys

Journal of Virology

Volumn 76, Issue 8, 2002, Pages 3965-3973

  Margolin, David H ^a   Helmuth Saunders, Erika F ^a   Bronfin, Benjamin ^a   De Rosa, Nicole ^a   Axthelm, Michael K ^a   Alvarez, Xavier ^a   Letvin, Norman L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL AGGREGATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GERMINAL CENTER; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE HYPERPLASIA; LYMPHADENOPATHY; LYMPHOID TISSUE; MONKEY DISEASE; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; RHESUS MONKEY; SPLEEN; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

ANIMALS; B-LYMPHOCYTES; BIOTINYLATION; GERMINAL CENTER; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MICE; RECOMBINANT PROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0036194520     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.8.3965-3973.2002     Document Type: Article

References (55)

1. HIV-1-specific B cell activation: A major constituent of spontaneous B cell activation during HIV-1 infection
2. The molecular structure of human antibodies specific for the human immunodeficiency virus
3. Induction of long-lived germinal centers associated with persisting antigen after viral infection
4. HIV and SIV gp120 binding does not predict coreceptor function
5. Immunoglobulin VH3 gene products: Natural ligands for HIV gp120
6. Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients
7. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: Oligomer-specific and -sensitive monoclonal antibodies
8. Morphologic changes in lymph nodes of macaques with an immunodeficiency syndrome
9. Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys
10. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
11. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors
12. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex
13. Identification of cell subsets expressing intracytoplasmic cytokines within HIV-1-infected lymph nodes
14. Lymphadenopathy in homosexual men: Morbid anatomy with clinical and immunologic correlations
15. Follicular dendritic cells and human immunodeficiency virus infectivity
16. Human immunodeficiency virus type 1 TAT protein activates B lymphocytes
17. Germinal centre CD4+ T cells are an important site of HIV replication in vivo
18. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyhl. I. The architecture and dynamics of responding cell populations
19. In situ studies of the primary immune response to NP. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers
20. Relative frequencies of secondary B cells activated by cognate vs. other mechanisms
21. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys
22. The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques
23. Accumulation of somatic hypermutation and antigen-driven selection in rapidly cycling surface Ig+ germinal center (GC) B cells which occupy GC at a high frequency during the primary anti-hapten response in mice
24. Double immunocytochemical staining for in vivo detection of epitope specificity and isotype of antibody-forming cells against synthetic peptides homologous to human immunodeficiency virus-1
25. Immunocytochemical determination of antigen and epitope specificity of HIV-1-specific B cells in lymph-node biopsies from HIV-1-infected individuals
26. CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients
27. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development
28. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells
29. In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients
30. Immunoglobulin VH usage during primary infection of rhesus monkeys with simian-human immunodeficiency viruses
31. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load
32. Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus
33. A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells
34. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
35. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV
36. Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity
37. Lymphatic tissue changes in AIDS and other retrovirus infections: Tools and insights
38. A chimeric simian/human immunodeficiency virus expressing a primary patient HIV-1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
39. An env gene derived from a primary HIV-1 isolate confers high in vivo replicative capacity to a chimeric simian-human immunodeficiency virus in rhesus monkeys
40. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein
41. Viral superantigen-induced hyporesponsiveness of T cells and polyclonal B cell activation in HIV-1 infection
42. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation
43. Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection
44. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS
45. Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients
46. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy
47. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
48. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody
49. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion
50. Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: Correlation with a Th1-type cytokine response
51. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines
52. The antigenic structure of the HIV gp120 envelope glycoprotein
53. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection
54. Frequencies of HIV-reactive B cells in seropositive and seronegative individuals